Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director/PDMR Shareholding

25 Apr 2022 07:00

RNS Number : 1331J
M. P. Evans Group PLC
25 April 2022
 

M.P. EVANS GROUP PLC

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

M.P. Evans Group Plc

(the "Company" or "M.P. Evans")

 

PDMR transaction

and

Total Voting Rights

PDMR transaction

 

The Company has been notified of the exercise of share options under the M.P. Evans Group PLC 2012 Unapproved Executive Share Option Plan by K.Chandra Sekaran, a director of the Company. K.Chandra Sekaran exercised his share options over 30,000 shares of 10p each in the capital of the Company ("Shares") granted at 483.21 per Share and due to expire on 19 June 2022.

 

Admission of the 30,000 new Shares has been satisfied via the block listing for the 2012 Executive Share Option Scheme (unapproved).

 

Simultaneously, K. Chandra Sekaran sold 14,000 Shares at 1061 pence per Share in order to fund the cost of exercise of the share options.

 

Total Voting Rights

 

Following the above transactions the Company has 54,726,253 Shares in issue. All of the Shares have equal voting rights and there are no Shares held in Treasury.

 

The above figure of 54,726,253 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

 1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

K. Chandra Sekaran

2

Reason for the notification

 

a)

Position/status

 

Executive director

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

M.P.Evans Group PLC

b)

LEI

 2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Shares of 10 pence per share in M.P.Evans Group PLC ("Shares").

 

Identification code: ISIN GB007538100

 

b)

Nature of the transaction

(i) Exercise of options over Shares

(ii) Sale of Shares

 

c)

Price(s) and volume(s)

 

(i) Exercise of share options over Shares:

Price(s) 483.21

Volume(s) 30,000

 

(ii) Sale of Shares:

Price(s) 1061p

Volume(s) 14,000

 

 

d)

Aggregated information

 

N/A

 

e)

Date of transaction

22 April 2022

f)

Place of transaction

(i)Outside trading venue

(ii)London Stock Exchange (XLON);AIM

 

25 April 2022

 

Enquiries:

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster

Andrew Clark

Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern

Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack

Elfie Kent

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEWEELEESEDL
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.